Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Nephrology and Hypertension|June 20, 2003
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patientsCharles R Nolan, Wajeh Y Qunibi
Kidney International. Supplement|August 7, 2004
Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implicationsBarton Brezina, Wajeh Y Qunibi, Charles R Nolan
Kidney International. Supplement|November 2, 2002
Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenonWajeh Y Qunibi, Charles A Nolan, J Carlos Ayus
Hemodialysis International. International Symposium on Home Hemodialysis|March 20, 2015
Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patientsGaurav Agarwal, Karina Vasquez, Neena Penagaluru, et al.
Journal of Nephrology|July 2, 2003
Kaposi's sarcoma in Sudanese renal transplant recipients: a report from a single centerAbdalla I Sabeel, Wajeh Y Qunibi, Osman A Alfurayh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2010
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patientsWajeh Y Qunibi, Carlos Martinez, Mark Smith, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|February 20, 2018
Vascular access mortality and hospitalization among hemodialysis patients in PalestineSondus A Hamadneh, Saja A Nueirat, Jamal Qadoomi', et al.
Kidney International|June 16, 2005
Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetesWajeh Y Qunibi, Fadi Abouzahr, Mohammad R Mizani, et al.
JAMA|November 18, 2014
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trialMikhail Kosiborod, Henrik S Rasmussen, Philip Lavin, et al.
Kidney International|April 17, 2004
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study)Wajeh Y Qunibi, Robert E Hootkins, Laveta L McDowell, et al.
Pageof 3